论文部分内容阅读
目的:探讨月经过多诊刮后置曼月乐的疗效价值。方法:2008年6月～2009年10月在两家医疗机构选择有排卵型月经过多患者90例,接受3种治疗方式,对所有病例治疗后进行为期1年的随访,记录其治疗效果。结果:共71例有随访结果,其中接受诊断性刮宫同时置入曼月乐(A组)、月经第4～7天直接置入曼月乐(B组)、单纯诊断性刮宫(C组)3种方式的患者分别为24、22、25例。PBAC评分在第1、2、3、6、12月3组差异均有统计学意义(P<0.05);血红蛋白在第1、2、3、6月差异无统计学意义,12月则显示差异有统计学意义(P<0.05)。点滴状出血发生率在第1、2、3、6月3组间差异均有统计学意义,B组的发生率一直最高,A组次之,C组发生率最低。结论:曼月乐治疗有排卵型月经过多可有效减少月经量,提高血红蛋白且患者满意度较好。结合诊断性刮宫可准确诊断导致月经过多的器质性病变,值得在临床推广。
Objective: To investigate the value of menopause after menorrhagia. Methods: From June 2008 to October 2009, 90 patients with ovulatory menorrhagia were selected in two medical institutions. Three kinds of treatment were accepted. All patients were followed up for one year after treatment, and the therapeutic effect was recorded. Results: A total of 71 patients had follow-up results, of which patients undergoing diagnostic curettage also received Mirena (group A). Menstrual music (group B), simple curettage (group C) Three ways of patients were 24,22,25 cases. There was significant difference in PBAC score between the 1st, 2nd, 3rd, 6th, and 12th month (P <0.05); hemoglobin had no significant difference at 1st, 2nd, 3rd and 6th month There was statistical significance (P <0.05). The incidence of drip-like bleeding in the 1st, 2nd, 3rd, and 6th month was significantly different among the three groups. The incidence of B group was the highest, followed by that of A group and the lowest of C group. Conclusion: Mirena treatment of ovulatory menorrhagia can effectively reduce the amount of menstruation, improve hemoglobin and patient satisfaction is better. Combined with diagnostic curettage can accurately diagnose the organic disease leading to menorrhagia, it is worth in the clinical promotion.